ARVO 2021: First-in-Human Study Indicates Efficacy of Encapsulated Lacritin in Primary Sjögren’s Syndrome Dry Eye
Ideal dosing and duration of administration are yet to be established
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.